# Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mitochondrial-pathway-signature-mitops-predicts-immunotherapy-response-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Pengpeng Zhang,Mengzhe Zhang,Jian-Lan Liu,Zhaokai Zhou,Lianmin Zhang,Peng Luo,Zhenfa Zhang |
| Citations | 57 |
| DOI | 10.1136/jitc-2025-012069 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jitc.bmj.com/content/13/7/e012069.full.pdf |
| OpenAlex ID | https://openalex.org/W4412779862 |
| PMID | 40744665 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Zhaokai Zhou](https://scholariq.org/researchers/zhaokai-zhou/)

## Paper primary topic

- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Paper topics

- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.